Clinical manifestations of inflammatory bowel disease: East and West differences

被引:101
作者
Wang, Yu Fang [1 ]
Zhang, Hu [1 ]
Ouyang, Qin [1 ]
机构
[1] Sichuan Univ, Dept Gastroenterol, W China Hosp, Chengdu 610041, Sichuan Provinc, Peoples R China
关键词
Chrohn's disease; clinical manifestation; inflammatory bowel disease; ulcerative colitis;
D O I
10.1111/j.1443-9573.2007.00296.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Inflammatory bowel disease (IBD) is very common in developed countries, while it is relatively uncommon in Asian countries. However, the incidence of IBD has been increasing in some Asian countries in recent years. Most cases of ulcerative colitis (UC) in Asia are of the chronic relapsing type, run a milder course, and the fulminant type is rarely seen. There is no difference in clinical manifestations between Asian and developed countries. The incidence of Crohn's Disease (CD) is mainly in males in Asia, while it is mainly in females in developed countries. The clinical manifestations of CD are similar between both sets of countries. In China there are less fistulae and perianal diseases, and extraintestinal manifestations of CD are uncommon. In China, 5.6% of patients with UC have a family history, which is lower than 10-20% in developed countries. NOD2/CARD15 variants in the locus of 16q112 (IBD1) are significantly associated with the susceptibility of CD in developed countries, but NOD2/CARD15 variants have not been found in Asian CD patients.
引用
收藏
页码:121 / 127
页数:7
相关论文
共 52 条
[1]
Inflammatory bowel disease in Iran: A review of 457 cases [J].
Aghazadeh, R ;
Zali, MR ;
Bahari, A ;
Amin, K ;
Ghahghaie, F ;
Firouzi, F .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2005, 20 (11) :1691-1695
[2]
AGREZ MV, 1982, MAYO CLIN PROC, V57, P747
[3]
*APDW2004 CHIN IBD, 2006, CHIN J DIG, V26, P368
[4]
Belaiche J, 1999, AM J GASTROENTEROL, V94, P2177
[5]
Bernstein CN, 1999, AM J EPIDEMIOL, V149, P916, DOI 10.1093/oxfordjournals.aje.a009735
[6]
Guidelines for the management of inflammatory bowel disease in adults [J].
Carter, MJ ;
Lobo, AJ ;
Travis, SPL .
GUT, 2004, 53 :v1-v16
[7]
Chinese Society of Gastroenterology Chinese Medical Association, 2001, CHINESE J INTERN MED, V40, P138
[8]
COHEN Z, 1987, GASTROENTEROL CLIN N, V16, P175
[9]
The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease [J].
Cuthbert, AP ;
Fisher, SA ;
Mirza, MM ;
King, K ;
Hampe, J ;
Croucher, PJP ;
Mascheretti, S ;
Sanderson, J ;
Forbes, A ;
Mansfield, J ;
Schreiber, S ;
Lewis, CM ;
Mathew, CG .
GASTROENTEROLOGY, 2002, 122 (04) :867-874
[10]
THE EPIDEMIOLOGY OF INFLAMMATORY BOWEL-DISEASE - A LARGE, POPULATION-BASED STUDY IN SWEDEN [J].
EKBOM, A ;
HELMICK, C ;
ZACK, M ;
ADAMI, HO .
GASTROENTEROLOGY, 1991, 100 (02) :350-358